SAR1B and chylomicron retention disease: Recently, we have shown that the total silencing of SAR1B (SAR1B−/−) lessens but does not extinguish the output of TG-rich lipoproteins (13) in intestinal cells, as is the case for patients with CRD (6, 10, 14).